Azacitidine Injection
Dr. Reddy's Laboratories, Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 12/18/2020
- Package NDC
- 43598-305-62
- Generic name
- Azacitidine Injection
- Contact info
- 866-732-3952
- Availability
- Available
- Related info
- Available to existing customers
- Update date
- 10/20/2026
- Dosage form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg (NDC 43598-305-62)
- Company name
- Dr. Reddy's Laboratories, Inc.
- Status
- Current
- Therapeutic category
- Oncology
- Harmonized identifiers (openFDA)
- Application number
- ANDA201537
- Brand name
- AZACITIDINE
- Generic name
- AZACITIDINE
- Manufacturer name
- Dr. Reddy's Laboratories Inc.
- Product NDC
- 43598-305
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Substance name
- AZACITIDINE
- RxCUI
- 485246
- SPL ID
- 35e92030-ae2f-04b2-c3de-69f8c8da6b82
- SPL set ID
- 71d8d758-86c9-b571-aed1-719654fd4b82
- Package NDC
- 43598-305-62
- Nui
- N0000000233, N0000175595
- Pharm class moa
- Nucleic Acid Synthesis Inhibitors [MoA]
- Pharm class epc
- Nucleoside Metabolic Inhibitor [EPC]
- UNII
- M801H13NRU